Thank you for subscribing!
Finfeed Archived May 31, 2021
Advanced Human Imaging Limited (ASX: AHI) has signed a binding term sheet with INTER-PSY B.V (Inter-Psy), a Netherlands based mental health and addition care company that has developed Health i Check, a preventative health screening app for the Dutch and European markets.
Finfeed Archived Mar 18, 2021
Australia’s federal government will grant $15M to clinical studies that explore the use of psychedelic drugs like magic mushrooms and ecstasy, to treat Australians with debilitating mental illnesses.
Finfeed Archived Mar 15, 2021
Creso Pharma Limited (ASX:CPH, FRA:1X8) has signed an agreement to acquire Halucenex Life Sciences Inc. (Halucenex), an established psychedelics company focused on developing treatments for Treatment Resistant Depression in individuals suffering from PTSD, and other mental health illnesses.
Next Investors Mar 15, 2021
Creso Pharma (ASX: CPH) will be the first ASX listed stock to acquire 100% of a psychedelics company. CPH is set to acquire Canada based Halucenex Life Sciences Inc., an established psychedelics company developing treatments for a range of mental illnesses.
Get expert stock analysis direct in your inbox
Join Our Mailing List
